How do you pay?
Which strength? Pick yours
How many tablets?

How to pay the least

From

$9 for 30 tablets, any strength

Generic verapamil ER at Walmart

What to do

  1. Ask your prescriber to send the prescription to your nearest Walmart. Or ask the store’s pharmacy to transfer it from your pharmacy.Find the nearest store 
  2. Ask for generic verapamil ER.See Walmart’s price list 

Other ways

Rather have it mailed? From $12 a month from Rx Outreach, by mail. Make a free account, then have your prescription sent there.

Open Rx Outreach 

Every company’s verapamil ER is rated by the FDA to work the same, so any pharmacy can fill your prescription with the one it stocks.

See every pharmacy’s price

Where to buy it

Pharmacies’ own cash prices for generic verapamil, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Who makes it

3 companies sell verapamil in this form, each one rated by the FDA as a substitute for the others. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Glenmark PharmaceuticalsER tablet 120 mg, 180 mg, 240 mg

    Product page on glenmarkpharma-us.com

    How it looks, what’s in it, NDCs

    120 mg Brown, oval, 11 mm, marked “292”

    PackageNDC
    Bottle of 9068462-292-90
    Bottle of 10068462-292-01
    Bottle of 50068462-292-05

    180 mg Brown, oval, 13 mm, marked “293”

    PackageNDC
    Bottle of 9068462-293-90
    Bottle of 10068462-293-01
    Bottle of 50068462-293-05

    240 mg Brown, oval, 19 mm, marked “G74”

    PackageNDC
    Bottle of 3068462-260-30
    Bottle of 9068462-260-90
    Bottle of 10068462-260-01
    Bottle of 50068462-260-05
    Bottle of 100068462-260-10

    Inactive ingredients: silicon dioxide, sodium alginate, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, titanium dioxide, polyethylene glycol 400, ferric oxide yellow, ferric oxide red, ferrosoferric oxide

    FDA label

  • Nivagen PharmaceuticalsER tablet 120 mg, 180 mg, 240 mg

    Has a dye: FD&C Blue No. 1 · Made by Cadila Pharmaceuticals

    How it looks, what’s in it, NDCs

    120 mg LIGHT BLUE, oval, 11 mm, marked “V12”

    PackageNDC
    Bottle of 10075834-320-01
    Bottle of 50075834-320-05

    180 mg LIGHT BLUE, oval, 16 mm, marked “C / 75”

    PackageNDC
    Bottle of 10075834-158-01
    Bottle of 50075834-158-05

    240 mg LIGHT BLUE, oval, 19 mm, marked “C / 77”

    PackageNDC
    Bottle of 10075834-159-01
    Bottle of 50075834-159-05

    Inactive ingredients: silicon dioxide, hypromellose 2910 (6 mpa.s), magnesium stearate, cellulose, microcrystalline, polyethylene glycol, povidone, sodium alginate, FD&C Blue No. 1, ferric oxide yellow, titanium dioxide, triacetin

    FDA label

  • Zydus LifesciencesTablet 120 mg, 180 mg, 240 mg
    How it looks, what’s in it, NDCs

    120 mg Beige, oval, 11 mm, marked “61 / 5”

    PackageNDC
    Bottle of 10068382-561-01
    Bottle of 50068382-561-05

    180 mg Beige, oval, 15 mm, marked “562”

    PackageNDC
    Bottle of 10068382-562-01
    Bottle of 50068382-562-05

    240 mg Beige, oval, 18 mm, marked “563”

    PackageNDC
    Bottle of 10068382-563-01
    Bottle of 50068382-563-05

    Inactive ingredients: cellulose, microcrystalline, sodium alginate, povidone k30, magnesium stearate, hypromellose 2910 (5 mpa.s), titanium dioxide, polyethylene glycol 400, talc, ferric oxide yellow, ferric oxide red

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What to say at the pharmacy

“Before you fill it, what would I pay for generic verapamil?”

Paying cash? Ask for the cash price. With insurance, ask what your plan charges.

What it’s used for

What the FDA label says

Verapamil hydrochloride extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

Source: the FDA label for Verapamil ER (Glenmark Pharmaceuticals Inc., USA), December 2, 2025. Full label on DailyMed 

Good to know

  • Different companies’ verapamil can look different. The FDA requires each to work the same way.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.